Drug intelligence / Profile preview

dichloroquine

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral, Topical, Intravenous, Intraperitoneal
01

Overview

Dichloroquine is a non-specific term used in pharmaceutical and toxicological literature to refer to several distinct chlorinated quinoline derivatives. Most commonly, in historical medical contexts such as the study of Subacute Myelo-Optico-Neuropathy (S.M.O.N.), it refers to **5,7-dichloro-8-quinolinol** (INN: **chlorquinaldol**), a halogenated hydroxyquinoline with antibacterial and antifungal properties used primarily for skin infections. In the field of antimalarial research, the term is often used as a shorthand for **4,7-dichloroquinoline**, a critical chemical intermediate in the synthesis of 4-aminoquinoline drugs like chloroquine. Additionally, the name has been applied to novel experimental derivatives, such as the heme-binding compound **CQ-D2**, which are investigated for their ability to prevent oxidative damage in hemoglobinopathies like beta-thalassemia or to enhance curative outcomes in cerebral malaria.

Other names
5,7-dichloro-8-quinolinolchlorquinaldol4,7-dichloroquinoline5,7-dichloro-8-hydroxyquinoline4,7-dichloroquine
02

Targets

Heme

Beyond the preview

Go deeper on dichloroquine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dichloroquine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call